Copyright
©The Author(s) 2025.
World J Psychiatry. May 19, 2025; 15(5): 103628
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.103628
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.103628
Table 1 Comparison of clinical features of patients in different groups, mean ± SD/n (%)
Clinical feature | Total number of patients (n = 108) | Thyroid cancer group (n = 48) | Benign nodule group (n = 30) | Mental disorder group (n = 30) | χ2/F | P value |
Age (years) | 56.27 ± 6.51 | 56.67 ± 6.25 | 56.17 ± 7.06 | 55.76 ± 6.58 | 0.183 | 0.833 |
Gender | 0.158 | 0.924 | ||||
Male | 50 (46.30) | 23 (47.92) | 13 (43.33) | 14 (46.67) | ||
Female | 58 (53.70) | 25 (52.08) | 17 (56.67) | 16 (53.33) | ||
BMI (kg/m2) | 23.21 ± 3.48 | 23.11 ± 3.57 | 23.26 ± 3.62 | 23.35 ± 3.29 | 0.046 | 0.955 |
Smoking history | 24 (22.22) | 14 (29.17) | 6 (20.00) | 4 (13.33) | 2.796 | 0.247 |
Drinking history | 32 (29.63) | 19 (39.58) | 7 (23.33) | 6 (20.00) | 4.185 | 0.123 |
Duration of mental disorders (years) | 3.48 ± 0.62 | 3.54 ± 0.21 | 3.49 ± 0.32 | 3.41 ± 0.24 | 2.440 | 0.092 |
FT3 (pmol/L) | 16.20 ± 4.66 | 18.96 ± 2.54 | 16.25 ± 5.33 | 11.75 ± 2.85 | 36.979 | 0.000 |
FT4 (pmol/L) | 38.87 ± 20.20 | 52.23 ± 18.41 | 39.52 ± 12.33 | 16.85 ± 2.65 | 59.105 | 0.000 |
TSH (mU/L) | 2.94 ± 0.47 | 2.96 ± 0.46 | 2.89 ± 0.54 | 2.94 ± 0.41 | 0.206 | 0.814 |
TT3 (nmol/L) | 2.04 ± 0.28 | 2.03 ± 0.24 | 2.05 ± 0.28 | 2.04 ± 0.19 | 0.065 | 0.937 |
TT4 (nmol/L) | 107.58 ± 21.31 | 106.33 ± 22.41 | 111.31 ± 19.63 | 105.85 ± 21.36 | 0.637 | 0.531 |
ALT (U/L) | 27.73 ± 10.81 | 32.65 ± 11.52 | 28.45 ± 7.69 | 19.13 ± 6.34 | 19.555 | 0.000 |
AST (U/L) | 27.75 ± 5.38 | 28.13 ± 5.65 | 27.95 ± 4.98 | 26.95 ± 5.41 | 0.468 | 0.628 |
ALP (U/L) | 84.27 ± 22.42 | 87.15 ± 21.74 | 84.96 ± 22.14 | 78.98 ± 23.54 | 1.252 | 0.290 |
TBil (μmol/L) | 15.86 ± 5.69 | 18.13 ± 5.58 | 16.23 ± 4.16 | 11.85 ± 5.11 | 14.151 | 0.000 |
TP (g/L) | 72.76 ± 5.76 | 73.26 ± 6.35 | 72.99 ± 5.18 | 71.72 ± 5.34 | 0.691 | 0.504 |
ALB (g/L) | 43.22 ± 5.84 | 41.54 ± 6.94 | 43.79 ± 5.29 | 45.33 ± 3.18 | 4.345 | 0.015 |
Cortisol (nmol/L) | 178.77 ± 28.43 | 198.41 ± 16.98 | 179.87 ± 14.13 | 146.23 ± 24.11 | 72.976 | 0.000 |
NE (ng/L) | 277.50 ± 69.03 | 326.85 ± 56.31 | 249.85 ± 44.18 | 226.17 ± 54.25 | 39.491 | 0.000 |
Ang II (ng/mL) | 18.89 ± 5.84 | 23.68 ± 4.98 | 15.79 ± 2.54 | 14.32 ± 3.15 | 64.523 | 0.000 |
SOD (nU/mL) | 92.99 ± 22.98 | 76.25 ± 6.21 | 95.34 ± 6.41 | 117.41 ± 27.54 | 66.166 | 0.000 |
- Citation: Jia JL, Han JH, Pang R, Bi W, Liu B, Yang K. Predictors of poor prognosis in long-term survivors of differentiated thyroid cancer with psychiatric disorders. World J Psychiatry 2025; 15(5): 103628
- URL: https://www.wjgnet.com/2220-3206/full/v15/i5/103628.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i5.103628